Outcomes | Group | Baseline prevalence (%) | End-line prevalence (%) | Odds ratioa (OR) | 95% CI | p-value** |
---|---|---|---|---|---|---|
Stuntingb | Control | 19.7 | 18.9 | 0.91 | 0.56–1.49 | |
SG-intervention | 17.7 | 19.5 | 1.17 | 0.62–2.20 | 0.54 | |
Combined intervention (SG+) | 19.9 | 18.3 | 0.88 | 0.49–1.56 | 0.92 | |
Thinnessb | Control | 12.3 | 7.1 | 0.47 | 0.24–0.94 | |
SG-intervention | 9.7 | 10.4 | 1.09 | 0.48–2.48 | 0.12 | |
Combined intervention (SG+) | 5.7 | 9.9 | 2.10 | 0.88–5.02 | < 0.01 | |
Anaemiac | Control | 22.7 | 41.3 | 3.06 | 1.97–4.77 | |
SG-intervention | 20.7 | 43.9 | 3.77 | 2.17–6.56 | 0.56 | |
Combined intervention (SG+) | 33.0 | 32.0 | 0.94 | 0.59–1.51 | < 0.01 | |
Intestinal parasitic infections | Control | 43.9 | 42.4 | 0.95 | 0.67–1.36 | |
SG-intervention | 33.5 | 27.4 | 0.75 | 0.46–1.20 | 0.42 | |
Combined intervention (SG+) | 37.1 | 9.4 | 0.16 | 0.09–0.29 | < 0.01 |